×
S&P 500   3,977.31 (+0.91%)
DOW   32,116.71 (+0.59%)
QQQ   291.63 (+1.53%)
AAPL   140.69 (+0.24%)
MSFT   262.54 (+1.12%)
FB   183.64 (+1.30%)
GOOGL   2,115.17 (-0.20%)
AMZN   2,136.96 (+2.64%)
TSLA   661.05 (+5.24%)
NVDA   168.64 (+4.40%)
BABA   82.29 (-0.22%)
NIO   14.64 (+0.07%)
AMD   92.92 (+1.93%)
CGC   5.04 (+5.88%)
MU   68.05 (+2.15%)
T   21.28 (+0.57%)
GE   74.24 (-0.38%)
F   12.73 (+2.50%)
DIS   103.30 (+1.68%)
AMC   11.69 (+12.51%)
PFE   53.81 (+0.75%)
PYPL   79.91 (+1.60%)
NFLX   187.11 (+3.75%)
S&P 500   3,977.31 (+0.91%)
DOW   32,116.71 (+0.59%)
QQQ   291.63 (+1.53%)
AAPL   140.69 (+0.24%)
MSFT   262.54 (+1.12%)
FB   183.64 (+1.30%)
GOOGL   2,115.17 (-0.20%)
AMZN   2,136.96 (+2.64%)
TSLA   661.05 (+5.24%)
NVDA   168.64 (+4.40%)
BABA   82.29 (-0.22%)
NIO   14.64 (+0.07%)
AMD   92.92 (+1.93%)
CGC   5.04 (+5.88%)
MU   68.05 (+2.15%)
T   21.28 (+0.57%)
GE   74.24 (-0.38%)
F   12.73 (+2.50%)
DIS   103.30 (+1.68%)
AMC   11.69 (+12.51%)
PFE   53.81 (+0.75%)
PYPL   79.91 (+1.60%)
NFLX   187.11 (+3.75%)
S&P 500   3,977.31 (+0.91%)
DOW   32,116.71 (+0.59%)
QQQ   291.63 (+1.53%)
AAPL   140.69 (+0.24%)
MSFT   262.54 (+1.12%)
FB   183.64 (+1.30%)
GOOGL   2,115.17 (-0.20%)
AMZN   2,136.96 (+2.64%)
TSLA   661.05 (+5.24%)
NVDA   168.64 (+4.40%)
BABA   82.29 (-0.22%)
NIO   14.64 (+0.07%)
AMD   92.92 (+1.93%)
CGC   5.04 (+5.88%)
MU   68.05 (+2.15%)
T   21.28 (+0.57%)
GE   74.24 (-0.38%)
F   12.73 (+2.50%)
DIS   103.30 (+1.68%)
AMC   11.69 (+12.51%)
PFE   53.81 (+0.75%)
PYPL   79.91 (+1.60%)
NFLX   187.11 (+3.75%)
S&P 500   3,977.31 (+0.91%)
DOW   32,116.71 (+0.59%)
QQQ   291.63 (+1.53%)
AAPL   140.69 (+0.24%)
MSFT   262.54 (+1.12%)
FB   183.64 (+1.30%)
GOOGL   2,115.17 (-0.20%)
AMZN   2,136.96 (+2.64%)
TSLA   661.05 (+5.24%)
NVDA   168.64 (+4.40%)
BABA   82.29 (-0.22%)
NIO   14.64 (+0.07%)
AMD   92.92 (+1.93%)
CGC   5.04 (+5.88%)
MU   68.05 (+2.15%)
T   21.28 (+0.57%)
GE   74.24 (-0.38%)
F   12.73 (+2.50%)
DIS   103.30 (+1.68%)
AMC   11.69 (+12.51%)
PFE   53.81 (+0.75%)
PYPL   79.91 (+1.60%)
NFLX   187.11 (+3.75%)
OTCMKTS:NMTC

NeuroOne Medical Technologies (NMTC) Stock Forecast, Price & News

$1.04
+0.08 (+8.33%)
(As of 05/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.88
▼
$1.08
50-Day Range
$0.53
▼
$2.24
52-Week Range
$0.51
▼
$7.97
Volume
106,932 shs
Average Volume
105,875 shs
Market Capitalization
$16.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
View Price History Chart DataSkip Price History Chart
30 days | 90 days | 365 days | Advanced Chart
Receive NMTC News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

NeuroOne Medical Technologies logo

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

Headlines

May 20, 2022 | americanbankingnews.com
Comparing NeuroOne Medical Technologies (NMTC) and Its Competitors
May 19, 2022 | msn.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.75%
May 19, 2022 | finance.yahoo.com
NeuroOne® to Present Its Breakthrough Technology for Monitoring Neural Activity at the H.C. Wainwright Global Investment Conference on May 25
May 17, 2022 | finance.yahoo.com
FDA Denies Approval For NeuroOne Medical's Evo sEEG Electrode For Extended Use
May 16, 2022 | finance.yahoo.com
NeuroOne Provides Evo® sEEG Update
May 13, 2022 | seekingalpha.com
NeuroOne Medical FQ2 Net Loss of $3.1M
May 13, 2022 | finance.yahoo.com
NeuroOne Reports Second Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
May 3, 2022 | finance.yahoo.com
NeuroOne® to Report Second Quarter Fiscal Year 2022 Financial Results on May 12
April 18, 2022 | finance.yahoo.com
NeuroOne® to Present its Disruptive Next-Generation Diagnostic Electrode Technology at the NobleCon18 Investor Conference on April 20, 2022
March 29, 2022 | marketwatch.com
NeuroOne Medical Shares Plummet as FDA Rejects Longer Electrode Use >NMTC
March 28, 2022 | msn.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.27%
March 28, 2022 | finance.yahoo.com
NeuroOne® to Host Investor Call About Recent Disclosures Tomorrow March 29th at 10:00 am ET
March 15, 2022 | finance.yahoo.com
Here's Why We're A Bit Worried About NeuroOne Medical Technologies' (NASDAQ:NMTC) Cash Burn Situation
See More Headlines

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:NMTC
Previous Symbol
CUSIP
N/A
CIK
1500198
Web
www.originalsourcemusic.com
Phone
(952) 426-1383
Fax
N/A
Employees
2,019
Year Founded
N/A

Sales & Book Value

Annual Sales
$180 thousand
Price / Sales
93.56
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.81 per share
Price / Book
1.28

Profitability

EPS (Most Recent Fiscal Year)
($0.840010)
Net Income
$-9.95 million
Net Margins
-6,946.06%
Pretax Margin
-6,945.46%
Return on Equity
-103.06%
Return on Assets
-93.51%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
16.60
Quick Ratio
16.32

Price-To-Earnings

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A

Miscellaneous

Outstanding Shares
16,193,000
Free Float
N/A
Market Cap
$16.84 million
Optionable
Not Optionable

Company Calendar

Last Earnings
12/15/2021
Today
5/25/2022
Fiscal Year End
9/30/2022

MarketRank™

Overall MarketRank™

1.61 out of 5 stars

Analyst Opinion: 3.3Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













NeuroOne Medical Technologies (OTCMKTS:NMTC) Frequently Asked Questions

Is NeuroOne Medical Technologies a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NeuroOne Medical Technologies in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NeuroOne Medical Technologies stock.
View analyst ratings for NeuroOne Medical Technologies or view top-rated stocks.

How were NeuroOne Medical Technologies' earnings last quarter?

NeuroOne Medical Technologies Co. (OTCMKTS:NMTC) issued its quarterly earnings data on Wednesday, December, 15th. The company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.24) by $0.02. The business earned $0.05 million during the quarter. NeuroOne Medical Technologies had a negative net margin of 6,946.06% and a negative trailing twelve-month return on equity of 103.06%.
View NeuroOne Medical Technologies' earnings history.

What price target have analysts set for NMTC?

2 equities research analysts have issued twelve-month price targets for NeuroOne Medical Technologies' shares. Their forecasts range from $2.00 to $3.25. On average, they anticipate NeuroOne Medical Technologies' stock price to reach $2.63 in the next twelve months. This suggests a possible upside of 152.4% from the stock's current price.
View analysts' price targets for NeuroOne Medical Technologies or view top-rated stocks among Wall Street analysts.

Who are NeuroOne Medical Technologies' key executives?
NeuroOne Medical Technologies' management team includes the following people:
  • Mr. David A. Rosa M.D., Pres, CEO & Director (Age 58, Pay $603.45k)
  • Mr. Ronald W. McClurg, Chief Financial Officer (Age 63, Pay $294.47k)
  • Mr. Steven Mertens, Chief Technology Officer (Age 60, Pay $298.97k)
  • Mr. Mark Christianson, Co-Founder, Bus. Devel. Director & Medical Sales Liaison (Age 55) (LinkedIn Profile)
  • Mr. Hijaz Haris, VP of Marketing
What other stocks do shareholders of NeuroOne Medical Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NeuroOne Medical Technologies investors own include Allena Pharmaceuticals (ALNA), Capcom (CCOEY), Iterum Therapeutics (ITRM), Aeglea BioTherapeutics (AGLE), Applied Genetic Technologies (AGTC), Ampliphi Biosciences (APHB), Axsome Therapeutics (AXSM), CVS Health (CVS), (NINE) and NIO (NIO).

What is NeuroOne Medical Technologies' stock symbol?

NeuroOne Medical Technologies trades on the OTCMKTS under the ticker symbol "NMTC."

Who are NeuroOne Medical Technologies' major shareholders?

NeuroOne Medical Technologies' stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (1.48%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends for NeuroOne Medical Technologies.

Which institutional investors are buying NeuroOne Medical Technologies stock?

NMTC stock was bought by a variety of institutional investors in the last quarter, including Vanguard Group Inc..
View insider buying and selling activity for NeuroOne Medical Technologies or or view top insider-buying stocks.

How do I buy shares of NeuroOne Medical Technologies?

Shares of NMTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NeuroOne Medical Technologies' stock price today?

One share of NMTC stock can currently be purchased for approximately $1.04.

How much money does NeuroOne Medical Technologies make?

NeuroOne Medical Technologies has a market capitalization of $16.84 million and generates $180 thousand in revenue each year. The company earns $-9.95 million in net income (profit) each year or ($0.840010) on an earnings per share basis.

How many employees does NeuroOne Medical Technologies have?

NeuroOne Medical Technologies employs 2,019 workers across the globe.

What is NeuroOne Medical Technologies' official website?

The official website for NeuroOne Medical Technologies is www.originalsourcemusic.com.

How can I contact NeuroOne Medical Technologies?

NeuroOne Medical Technologies' mailing address is 10006 Liatris Ln, EDEN PRAIRIE, MN 55347-1210, United States. The company can be reached via phone at (952) 426-1383 or via email at [email protected].

This page was last updated on 5/25/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.